Share

Dr. Cora Sternberg presented the long term results of EORTC trial 30994 at ASCO 2014 in Chicago

Cora-N.-SternbergDr. Cora N. Sternberg of the San Camillo and Forlanini Hospitals in Rome and study coordinator of EORTC trial 30994, presented the long term results of that trial at ASCO 2014 in Chicago. The results lend new support to use of immediate cisplatin-based chemotherapy following surgical resection. An overview of the trial results were reported in the 03 June 2014 ASCO Daily News.

Back to news list

Related News

  • EORTC: Advancing research and treatment for rare cancers

  • EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration

  • Appointment of Malte Peters as EORTC Strategic Alliance Officer

  • Unique series of workshops in partnership with the European Medicines Agency (EMA)

  • EORTC launches a prominent clinical trial in older patients with locally advanced (LA) HNSCC (Head and Neck Squamous Cell Carcinoma)

  • Seven IMMUcan abstracts selected for ESMO Immuno-Oncology Congress 2023

  • EORTC Quality of Life measures integrated in CDISC

  • EORTC and Immunocore are collaborating to launch the ATOM clinical trial of tebentafusp in Adjuvant Uveal Melanoma

  • Treatment with decitabine resulted in a similar survival and fewer adverse events compared with conventional chemotherapy in older fit patients with acute myeloid leukaemia

  • New results and forthcoming EORTC trials in rare cancers, lung, head and neck, and breast carcinomas presented at ESMO 2023